학술논문

Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib
Document Type
Article
Source
In: Internal and Emergency Medicine. (Internal and Emergency Medicine, June 2024, 19(4):1151-1160)
Subject
Language
English
ISSN
19709366
18280447